Circulating tumor cells as emerging tumor biomarkers in breast cancer (Q37908134)

25 August 2017

1 reference

title

Circulating tumor cells as emerging tumor biomarkers in breast cancer (English)

1 reference

25 August 2017

0 references

1 reference

Evi S Lianidou

1

1 reference

PubMed ID

21801030

25 August 2017

Athina Markou

series ordinal

2

1 reference

25 August 2017

29 July 2011

1 reference

Clinical Chemistry and Laboratory Medicine

25 August 2017

1 reference

25 August 2017

49

1 reference

25 August 2017

10

1 reference

25 August 2017

1579-1590

1 reference

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

25 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

A pooled analysis of bone marrow micrometastasis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Circulating tumour cell detection on its way to routine diagnostic implementation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Is there a role for circulating tumor cells in the management of breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

21 January 2018

Cancer micrometastases

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Pathology: are circulating tumor cells predictive of overall survival?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

HER-2 gene amplification can be acquired as breast cancer progresses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

What's new on circulating tumor cells? A meeting report

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Models, mechanisms and clinical evidence for cancer dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Tumor self-seeding by circulating cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

On the theory of tumor self-seeding: implications for metastasis progression in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Parallel progression of primary tumours and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Systemic spread is an early step in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

High-resolution array comparative genomic hybridization of single micrometastatic tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Complex networks orchestrate epithelial-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

MicroRNAs in clinical oncology: at the crossroads between promises and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Molecular characterization of circulating tumor cells in breast cancer by a liquid bead array hybridization assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Disseminated and circulating tumor cells: Role in effective cancer management

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Isolation by size of epithelial tumor cells : a new method for the immunomorphological and molecular characterization of circulatingtumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Portable filter-based microdevice for detection and characterization of circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Isolation of rare circulating tumour cells in cancer patients by microchip technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Highly efficient circulating tumor cell isolation from whole blood and label-free enumeration using polymer-based microfluidics with an integrated conductivity sensor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Detection, clinical relevance and specific biological properties of disseminating tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Detection and quantification of small numbers of circulating tumour cells in peripheral blood using laser scanning cytometer (LSC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Standardized quantification of circulating peripheral tumor cells from lung and breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Quantitative RT-PCR luminometric hybridization assay with an RNA internal standard for cytokeratin-19 mRNA in peripheral blood of patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Optimal markers for real-time quantitative reverse transcription PCR detection of circulating tumor cells from melanoma, breast, colon, esophageal, head and neck, and lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Molecular biomarker analyses using circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Circulating tumor cells in blood of primary breast cancer patients assessed by a novel RT-PCR test kit and comparison with status of bone marrow-disseminated tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Micrometastatic disease in breast cancer: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Detection of breast cancer cells in the peripheral blood is positively correlated with estrogen-receptor status and predicts for poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Detection and HER2 expression of circulating tumor cells: prospective monitoring in breast cancer patients treated in the neoadjuvant GeparQuattro trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Molecular mechanisms of metastasis in breast cancer--clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

HER2-positive circulating tumor cells in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Improving the yield of circulating tumour cells facilitates molecular characterisation and recognition of discordant HER2 amplification in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Cancer stem cells and epithelial-mesenchymal transition: revisiting minimal residual disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

Epithelial-to-mesenchymal transitions and circulating tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2011.628

21 January 2018

Identifiers

DOI

10.1515/CCLM.2011.628

1 reference

25 August 2017

1 reference

PubMed ID

21801030